期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Current Pharmaceutical Analysis LetPub Score 5.1
51 ratings
Rate
Reputation 6.1 Influence 3.6 Speed 8.4 | ||||||||||||||||||||||||||||
期刊簡稱 | CURR PHARM ANAL | ||||||||||||||||||||||||||||
ISSN | 1573-4129 | ||||||||||||||||||||||||||||
E-ISSN | 1875-676X | ||||||||||||||||||||||||||||
h-index | 22 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 14.30%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://benthamscience.com/journal/index.php?journalID=cpa | ||||||||||||||||||||||||||||
在線稿件提交 | http://benthamscience.com/journal/authors-guidelines.php?journalID=cpa#top | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Bentham Science Publishers B.V. | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | U ARAB EMIRATES | ||||||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||||||
創刊年 | 2005 | ||||||||||||||||||||||||||||
每年文章數 | 60每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 1.45% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1573-4129%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Current Pharmaceutical Analysis] 的評論 | 撰寫評論 |
作者: 蒙德瑜敏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-06 13:06:05 評論於 I also want to know(0) 讚! | 蒙德瑜敏 |
作者: 张 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-11-18 14:51:26 評論於 The third article on mass spectrometry analysis of peptide structures. It was submitted in February 2022 and officially published in November, which is considered relatively fast. Unfortunately, it is a paid article.(0) 讚! | 张 |
作者: zero 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-05 21:48:02 評論於 May I ask if the review process is fast? Do I need to pay for the publication?(0) 讚! | zero |
作者: 依巧酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-16 17:29:51 評論於 Hello, I would like to ask if the manuscript submitted last year will be accepted?(0) 讚! | 依巧酱大魔王 |
作者: 姝美小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-08 22:00:34 評論於 Both are needed(0) 讚! | 姝美小公主 |
作者: 如寒公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-15 21:37:56 評論於 Do we still need to pay publishing fees if this magazine does not choose OA?(0) 讚! | 如寒公子 |
作者: 困困 領域: 医学 審稿時間: 3.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-02 17:09:00 評論於 Excuse me, does this magazine require a layout fee?(0) 讚! | 困困 |
作者: 姝美小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-17 13:57:47 評論於 Review Speed: 3.0 | Submission Hit Rate: 75.0 | Page Fee: 3500.0 Emphasized Research Direction: Drug Analysis Experience sharing: Due to the impact of the epidemic and initially unclear image quality, the review process was slow. Submitted on August 24, 2020, reviewed on December 12, 2020, revised on December 26, 2020, accepted on February 14, 2021, and proofed on April 15, 2021(0) 讚! | 姝美小公主 |
作者: 张 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-12-14 12:04:32 評論於 It is an article on the discovery and structure identification of new drug impurities. The paper was submitted at the end of June 2020, and the minor revision was required on September 7th. The language was modified. After it was resubmitted, the DOI was assigned in early December, which was quite fast. Page numbering will be slower to be assigned, and it is scheduled for next year. (0) 讚! | 张 |
作者: 辉夜碧秋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-03 22:26:13 評論於 Do you accept meta-analysis?(0) 讚! | 辉夜碧秋 |
作者: 极乐琇晶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-12-03 13:33:24 評論於 How to review and provide feedback on this magazine(0) 讚! | 极乐琇晶 |
作者: 极乐琇晶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-12-03 10:40:14 評論於 How to view and make edits to this magazine?(0) 讚! | 极乐琇晶 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 08:19:30 評論於 Anyway, with this bearish trend, there is unlikely to be any change. As long as it doesn't fall, that would be fortunate(0) 讚! | 凌霄高洁 |
作者: 东海冷丝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-12-01 16:08:05 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Sharing Experience: My submission has been in for over 2 months, and the status hasn't changed at all. It's frustrating(0) 讚! | 东海冷丝 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-03 18:24:30 評論於 Review Speed: 1.0 Experience Sharing: The article I submitted was reviewed within two weeks, revised within a week, and accepted a few days after revision. The speed is quite fast(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-09-26 16:53:05 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: The articles I submitted took about one and a half months to be reviewed, and it took 5 months to be formally published. I feel that it is quite fast and the editors are very responsible(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us